# Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia

> clinical trial · VERIFIED · 2026-07-10

Status: RECRUITING · Sponsor: Princess Maxima Center for Pediatric Oncology · Condition: Acute Lymphoblastic Leukemia

- Company: Princess Maxima Center for Pediatric Oncology
- Sector: Acute Lymphoblastic Leukemia
- Primary source: https://clinicaltrials.gov/study/NCT05327894

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.